MY182607A - Combination composition, comprising as active ingredients l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency - Google Patents

Combination composition, comprising as active ingredients l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency

Info

Publication number
MY182607A
MY182607A MYPI2012002962A MYPI2012002962A MY182607A MY 182607 A MY182607 A MY 182607A MY PI2012002962 A MYPI2012002962 A MY PI2012002962A MY PI2012002962 A MYPI2012002962 A MY PI2012002962A MY 182607 A MY182607 A MY 182607A
Authority
MY
Malaysia
Prior art keywords
carnitine
propionyl
prevention
treatment
active ingredients
Prior art date
Application number
MYPI2012002962A
Inventor
Mohamed Ashraf Virmani
Aleardo Koverech
Original Assignee
Alfasigma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51844410&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY182607(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP10152363A external-priority patent/EP2353596A1/en
Application filed by Alfasigma Spa filed Critical Alfasigma Spa
Publication of MY182607A publication Critical patent/MY182607A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

It is described a combination composition comprising as active ingredients L--carnitine or propionyl L-carnitine, troxerutine, diosmine and hesperidine, useful for the prevention and/or treatment of chronic venous diseases.
MYPI2012002962A 2010-02-02 2011-02-07 Combination composition, comprising as active ingredients l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency MY182607A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10152363A EP2353596A1 (en) 2010-02-02 2010-02-02 Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency
US32253210P 2010-04-09 2010-04-09
PCT/IB2011/000200 WO2011095882A1 (en) 2010-02-02 2011-02-07 Combination composition, comprising as active ingredient l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency

Publications (1)

Publication Number Publication Date
MY182607A true MY182607A (en) 2021-01-26

Family

ID=51844410

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2012002962A MY182607A (en) 2010-02-02 2011-02-07 Combination composition, comprising as active ingredients l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency

Country Status (6)

Country Link
CA (1) CA2787470C (en)
CL (1) CL2012001740A1 (en)
HR (1) HRP20140785T1 (en)
MY (1) MY182607A (en)
SM (1) SMT201400121B (en)
ZA (1) ZA201206518B (en)

Also Published As

Publication number Publication date
ZA201206518B (en) 2013-05-29
SMT201400121B (en) 2014-11-10
CA2787470A1 (en) 2011-08-11
HRP20140785T1 (en) 2014-11-07
CL2012001740A1 (en) 2012-11-09
CA2787470C (en) 2018-03-27

Similar Documents

Publication Publication Date Title
MX2012008890A (en) Combination composition, comprising as active ingredient l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency.
WO2012083048A3 (en) Anti-viral compounds
WO2012083053A3 (en) Anti-viral compounds
TN2012000549A1 (en) Substituted 5-fluoro-1h-pyrazolopyridines and use thereof
NZ628294A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
WO2012083061A3 (en) Anti-viral compounds
IN2012DN00624A (en)
WO2012125544A3 (en) Necroptosis inhibitors and methods of use therefor
WO2012083058A3 (en) Anti-viral compounds
WO2011076367A3 (en) Synergistic antiviral composition and use thereof
WO2011042902A3 (en) Microcapsules comprising benzoyl peroxide and topical compositions comprising them
WO2012162580A3 (en) Anti-viral compounds
MX359181B (en) Collagen hydrolysate and use thereof.
WO2012162578A3 (en) Anti-viral compounds
WO2012024399A3 (en) Compositions comprising paulownin and/or paulownia extracts and uses thereof
MX2013002261A (en) Substituted n-phenethyltriazoloneacetamides and use thereof.
WO2011156820A9 (en) Compositions, methods and uses for treatment of type 1 diabetes
WO2012065028A3 (en) Substituted tetracyclines
MY182607A (en) Combination composition, comprising as active ingredients l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency
WO2014004178A3 (en) Compositions comprising substituted phenols and topical application thereof
WO2012064557A3 (en) Deodorizing compositions
NZ613887A (en) Antimicrobial activity enhancing agent
IN2014KN02584A (en)
WO2011073439A3 (en) Use of peptides as antidandruff agents
WO2010142981A3 (en) Composition and uses thereof